SUMMARY We have studied changes in left ventricular function with non-invasive nuclear angiography, at rest, during graded infusions of isoprenaline (0.75, 1 0, and 2-0 jig/min), and 10 minutes after a single intravenous injection of propranolol (0-25 mg/kg). To test the adequacy of beta-adrenoreceptor antagonism, isoprenaline (2.0 vg/min) was reinfused after propranolol. Eight healthy subjects have been studied. Ventricular volume-time curves were obtained by electrocardiogram-gated accumulation of count rates in sequential 20 ms time bins (over 500 cardiac cycles) from a selected region of interest corresponding to the left ventricular blood pool. 99mTc-HSA was used as the radiopharmaceutical. In addition to the ejection fraction, the mean ejection rate, peak rate of change of volume in systole and diastole, and the mean ejection and filling times were calculated from these volume-time curves. A linear dose dependance has been shown in the changes in ejection fraction, mean ejection rate, peak rate of change of volume in systole, and mean ejection time. After beta-adrenoreceptor antagonism the resting values of various variables were not significantly different from the control values, except for the mean ejection rate. Reinfusion of isoprenaline after beta-adrenoreceptor antagonism was without effect on any of the variables.
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This study shows that nuclear angiography provides a satisfactory non-invasive technique for the evaluation of cardiac function, especially when physiological and pharmacological interventions are examined.
Changes in ventricular volume can be measured at nuclear angiography by imaging a suitably labelled blood pool within the heart using a gamma camera system. The electrocardiogram-gated accumulation of radioactivity in sequential time bins yields an activity-time curve from which complementary variables of ventricular function may be measured. 
Subjects and methods
These studies were carried out in eight health. subjects drawn from a routine referral service for the investigation of acute chest pain. All subjects had a history of vague chest pain thought to be nonischaemic in origin. They also had normal findings on a detailed clinical examination, resting and exercise electrocardiograms (to a workload of 900 kpm), and chest x-ray films. Informed consent was obtained from all subjects and the study had the approval of our hospital ethical committee.
The patients were studied in the supine position. Possible thyroid uptake was blocked by two doses of potassium iodide given orally during the preceding 24 hours.
Cardiac blood pool imaging was performed in the 30°left anterior oblique projection with a 100 caudal tilt using a Nuclear Enterprises Mk 5 HR gamma camera fitted with a high resolution parallelhole collimator. Between 12 and 15 mCi of technetium-99m labelled to human serum albumin was injected into the left antecubital vein through an indwelling cannula and flushed in rapidly with a single 20 ml bolus of normal saline.
After resting measurements for 10 minutes, constant rate infusions of isoprenaline were given and cardiac imaging was continued. Three sequential incremental steps of isoprenaline infusion in the dose of 0 75, 1, and 2 ,ug/min were used. Each dose level was maintained for approximately 10 minutes. After this, beta-adrenoreceptor antagonism was produced with a single bolus of 0-25 mg/kg body weight of propranolol and the recordings repeated after a 10-minute wait. Lastly, isoprenaline infusion at a dose of 2 Vg/min was restarted while the measurements were continued.
During the procedure the electrocardiogram from a display unit, heart rate from a digital counter connected to the electrocardiograph, and blood pressure by sphygmomanometry were monitored continuously. The data from the gamma camera, together with a bipolar electrocardiogram derived from the chest leads, were recorded simultaneously in analogue form on videotape.
The ventricular volume curves were generated during replay of the data from the videotapes.' A region of interest corresponding to the left ventricle was selected on the gamma camera. Care was taken to exclude the left atrium and the right ventricle from the selected field of view. The count rates, along with the RR interval histogram, were transferred to a PDP 12 computer and ventricular volume curves plotted. The digital filtering technique to filter out the high-frequency noise from the raw data is described elsewhere.5
Volume curves showing a standard deviation of the RR interval of greater than 60 ms were rejected. Corrections were made for background counts and the ejection fraction (EF) was calculated.' The volume curve was differentiated to give the peak rate of change of volume in systole (dV8/dt) and diastole (dVd/dt). Mean times of ejection (i.) and filling (td) were calculated from the ventricular curve according to the general equation:
for values of ti throughout each phase of the cardiac cycle where Vi is the relative volume at time ti.
As a weighted mean these times represent the centre of gravity of the corresponding segments of the differentiated volume curve. In order to study the effect on ti and td values as a result of changes in the cycle length alone, without changes in inotropy, measurements were made at rest and at peak heart rates after each of two successive injections of atropine (600 ,ug each). The volume time curves for this purpose were obtained in a similar manner in another six patients recovering from a myocardial infarction.
The left ventricular ejection time (LVET) was measured from the volume-time curve as the interval between the end-diastolic and endsystolic channels. 
Results
The mean data for all subjects are given in Table 1 . The heart rate increased from a resting average of 78 beats per min to 106 beats per min at the maximum dose of isoprenaline used. The systolic blood pressure increased slightly (+ 13-0%) and tbe diastolic blood pressure decreased somewhat (-8&7%), resulting in the characteristic widening of the pulse pressure during infusions of isoprenaline ( Fig. 1 ). Fig. 2 shows the ventricular volume curves at rest and after each of the pharmacological interventions in one patient. For all subjects the ejection fraction at rest averaged 0O58 ±006 (SD) and increased to 070 +009 (SD) at an infusion rate of 0O75 ,ug/min (Iso 1), 0-72 ±0.10 (SD) at an infusion rate of 1 ,ug/min (Iso 2), and 0176 ±0-08 (SD) at an infusion rate of 2-0 ,ug/min (Iso 3). After beta-adrenoreceptor antagonism the mean ejection fraction of 0O52 ±0-07 (SD) was not significantly different from the resting values. Reinfusion of isoprenaline at 2-0 ,ug/min was now without effect (Fig. 3) (Fig. 4) . The effect of cycle length alone on ts and td was examined from data obtained at rest and after each of two successive injections of atropine. The correlation coefficient between i5 and LVET was 0'41 (p > 0 05) and between id and the left ventricular filling time (LVFT) this was 0 35 (p>0 > 1) over heart rates ranging from 63 to 121 beats per min (80-7 ±13-9 SD). The is/LVET ratio was 0 54 at rest and did not change significantly after injections of atropine, while the id/LVFT ratio increased progressively with the increase in heart rate ( Nuclear angiography provides a useful alternative method, especially when sequential measurements are desired. Three different approaches have been used for the study of global volume changes by nuclear angiography. Time-activity curves obtained during the first pass of a radioactive bolus5 12 13 have the advantage of a low background, but the disadvantage of relatively poor counting statistics. Furthermore, measurements cannot be repeated more than once during the same study period, except perhaps when using isotopes with ultrashort half-lives. The second approach requires serial accumulations of electrocardiogram-gated images at end-systole and end-diastole; the ejection fraction is then obtained either by computer subtraction'4 or from geometric area-length analyses.15 16 In either case only limited information about the ejection fraction is obtained. The latter method is handicapped by fallacies inherent in assumptions of ventricular geometry and ignores a major advantage of nuclear angiography. No assumptions of geometry need be made in the estimation of volume change by nuclear angiography since count density is proportional to volume.
The third approach is a modification of the second in that numerical data from gated acquisition of count rates are plotted in the form of a composite volume-time curve representing a single averaged cardiac cycle.' 417 18 Not only are sequential measurements possible, but information about volume change throughout the cardiac cycle is obtained. This method was therefore chosen for the present study. Since data were accumulated over several cardiac cycles measurements were restricted to "steady state" conditions.
In the present study, drugs with known pharmacological actions were chosen to examine the confidence with which changes in myocardial function (Fig. 5) . Considering the moderate doses of isoprenaline infusions, the results suggest that changes in myocardial function can be assessed with reasonable confidence by nuclear angiography. A similar order of magnitude of changes in ejection fraction with isoprenaline have been reported previously.23 24 Since pacinginduced tachycardia results in a decrease in ejection fraction (15% decrease in ejection fraction for a 34% increase in heart rate) and end-diastolic volume,25 the seemingly small increases in ejection fraction during infusions of isoprenaline assume greater significance. The changes in peak rate of change of volume may be expected to be a more sensitive index of changes in myocardial function. This measurement, however, is very sensitive to the degree of filtering to which the data are subjected (unpublished observations). In the present studies care was taken to ensure optimal filtering but, in the absence of a precise mathematical expression that defines the indices of an optimal filter, a certain element of subjective uncertainty is likely to affect adversely the value of this variable when measured at nuclear angiography.
The mean ejection rate, as a measure of the average velocity of flow, is more sensitive than the ejection fraction to changes in the inotropic state. After beta-adrenoreceptor antagonism a small but significant decrease was found in the mean ejection rate but not in the ejection fraction. The mean ejection time (is) represents the time taken to move 50 per cent of the total volume displaced during systole. The ratio is/LVET therefore helps to partition the mean ejection velocity into two periods of equal volume displacement. A ratio of 0.5 indicates a symmetrical velocity profile of ejection, whereas values of less than 0 5 indicate a more rapid ejection of the first 50 per cent of the stroke volume compared with the next 50 per cent. The latter would indicate a more forceful and rapid contraction during the earlier parts of systole compared with the later phases of systole, as is expected during inotropic stimulation. In the present study graded infusions of isoprenaline resulted in a progressive shortening of ir and a decrease in is/LVET ratio in association with a larger stroke volume and ejection fraction. On the other hand, tachycardia induced with atropine is without effect on the i5/LVET ratio and hence the velocity profile of ejection. A significant advantage is that unlike the dVs/dt values, is is not affected much by the filter bandwidth (unpublished observations).
In conclusion, therefore, 
